Suiseng Diff/A

Authorised

This medicine is authorised for use in the European Union

clostridioides difficile / clostridium perfringens vaccine, inactivated

Overview

Up-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website

Suiseng Diff/A : EPAR - Medicine Overview

Product information

Suiseng Diff/A : EPAR - Product Information

Suiseng Diff/A : EPAR - All authorised presentations

Product details

• Name of medicine:
  Suiseng Diff/A
• Active substance:
  • Clostridioides difficile toxoid A
  • Clostridioides difficile toxoid B
  • Clostridium perfringens, type A, alpha toxoid
• International non-proprietary name (INN) or common name:
  • clostridioides difficile
  • clostridium perfringens vaccine, inactivated

Pharmacotherapeutic group

Immunologicals for Suidae, inactivated bacterial vaccines for pigs, clostridium

Authorisation details

• EMA product number:
  EMEA/V/C/005596

Assessment history

Changes since initial authorisation of medicine

CVMP post-authorisation summary of positive opinion for Suiseng Diff/A

Adopted Reference Number: EMA/CVMP/436655/2023

Initial marketing authorisation documents

Suiseng Diff/A : EPAR - Public assessment report

Adopted

CVMP summary of positive opinion for Suiseng Diff/A

Adopted Reference Number: EMA/CVMP/522701/2021